Crystal structure of the von Willebrand factor A domain of human capillary morphogenesis protein 2: An anthrax toxin receptor

被引:101
|
作者
Lacy, DB
Wigelsworth, DJ
Scobie, HM
Young, JAT
Collier, RJ
机构
[1] Harvard Univ, Sch Med, Dept Microbiol & Mol Genet, Boston, MA 02115 USA
[2] Salk Inst Biol Studies, Infect Dis Lab, La Jolla, CA 92037 USA
关键词
D O I
10.1073/pnas.0401506101
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
Anthrax toxin is released from Bacillus anthracis as three monomeric proteins, which assemble into toxic complexes at the surface of receptor-bearing host cells. One of the proteins, protective antigen (PA), binds to receptors and orchestrates the delivery of the other two (the lethal and edema factors) into the cytosol. PA has been shown to bind to two cellular receptors: anthrax toxin receptor/tumor endothelial marker 8 and capillary morphogenesis protein 2 (CMG2). Both are type 1 membrane proteins that include an approximate to200-aa extracellular von Willebrand factor A (VWA) domain with a metal ion-dependent adhesion site (MIDAS) motif. The anthrax toxin receptor/tumor endothelial marker 8 and CMG2 VWA domains share approximate to60% amino acid identity and bind PA directly in a metal-dependent manner. Here, we report the crystal structure of the CMG2 VWA domain, with and without its intramolecular disulfide bond, to 1.5 and 1.8 Angstrom, respectively. Both structures contain a carboxylate ligand-mimetic bound at the MIDAS and appear as open conformations when compared with the VWA domains from alpha-integrins. The CMG2 structures provide a template to begin probing the high-affinity CMG2-PA interaction (200 pM) and may facilitate understanding of toxin assembly/internalization and the development of new anthrax treatments. The structural data also allow molecular interpretation of known CMG2 VWA domain mutations linked to the genetic disorders, juvenile hyaline fibromatosis, and infantile systemic hyalinosis.
引用
收藏
页码:6367 / 6372
页数:6
相关论文
共 50 条
  • [41] Crystal structure of the von Willebrand factor A1 domain in complex with the function blocking NMC-4 Fab
    Reha Celikel
    Kottayil I. Varughese
    Akira Madhusudan
    Jerry Yoshioka
    Zaverio M. Ware
    Nature Structural Biology, 1998, 5 : 189 - 194
  • [42] Primary structure of the propeptide and factor VIII-binding domain of bovine von Willebrand factor
    Janel, N
    Ribba, AS
    Cherel, G
    KerbiriouNabias, D
    Meyer, D
    BIOCHIMICA ET BIOPHYSICA ACTA-PROTEIN STRUCTURE AND MOLECULAR ENZYMOLOGY, 1997, 1339 (01): : 4 - 8
  • [43] Crystal structure of von Willebrand factor A1 domain in complex with the function blocking NMC-4 Fab
    Celikel, R
    Varughese, KI
    Yoshioka, A
    Ware, J
    Ruggeri, ZM
    THROMBOSIS AND HAEMOSTASIS, 1997, : HI9 - HI9
  • [44] Crystal structure of the SH3 domain of growth factor receptor-bound protein 2
    Bolgov, Alexandr
    Korban, Svetlana
    Luzik, Dmitrii
    Zhemkov, Vladimir
    Kim, Meewhi
    Rogacheva, Olga
    Bezprozvanny, Ilya
    ACTA CRYSTALLOGRAPHICA SECTION F-STRUCTURAL BIOLOGY COMMUNICATIONS, 2020, 76 : 263 - 270
  • [45] Two-dimensional analysis of the structure of human von Willebrand factor
    Perutelli, P
    Catellani, S
    Mori, PG
    HAEMATOLOGICA, 1998, 83 (09) : 859 - 860
  • [46] Purified A2 domain of von Willebrand factor binds to the active conformation of von Willebrand factor and blocks the interaction with platelet glycoprotein Ibα
    Martin, C.
    Morales, L. D.
    Cruz, M. A.
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2007, 5 (07) : 1363 - 1370
  • [47] Molecular modeling of the von Willebrand factor A2 Domain and the effects of associated type 2A von Willebrand disease mutations
    Jeffrey J. Sutherland
    Lee A. O’Brien
    David Lillicrap
    Donald F. Weaver
    Journal of Molecular Modeling , 2004, 10 : 259 - 270
  • [48] The crystal structure of human receptor protein tyrosine phosphatase κ phosphatase domain 1
    Eswaran, Jeyanthy
    Debreczeni, Judit .
    Longman, Emma
    Barr, Alastair J.
    Knapp, Stefan
    PROTEIN SCIENCE, 2006, 15 (06) : 1500 - 1505
  • [49] Molecular modeling of the von Willebrand factor A2 domain and the effects of associated type 2A von Willebrand disease mutations
    Sutherland, JJ
    O'Brien, LA
    Lillicrap, D
    Weaver, DF
    JOURNAL OF MOLECULAR MODELING, 2004, 10 (04) : 259 - 270
  • [50] STRUCTURE-FUNCTION RELATIONSHIP OF THE A1 DOMAIN OF VON-WILLEBRAND-FACTOR
    GIRMA, JP
    RIBBA, AS
    MEYER, D
    THROMBOSIS AND HAEMOSTASIS, 1995, 74 (01) : 156 - 160